{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,16]],"date-time":"2026-07-16T10:55:27Z","timestamp":1784199327315,"version":"3.55.0"},"reference-count":138,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,5,19]],"date-time":"2026-05-19T00:00:00Z","timestamp":1779148800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100017950","name":"Shanghai Municipal Health Commission","doi-asserted-by":"publisher","award":["2022YQ056"],"award-info":[{"award-number":["2022YQ056"]}],"id":[{"id":"10.13039\/100017950","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003399","name":"Science and Technology Commission of Shanghai Municipality","doi-asserted-by":"publisher","award":["23XD1404900"],"award-info":[{"award-number":["23XD1404900"]}],"id":[{"id":"10.13039\/501100003399","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003399","name":"Science and Technology Commission of Shanghai Municipality","doi-asserted-by":"publisher","award":["21ZR1478200"],"award-info":[{"award-number":["21ZR1478200"]}],"id":[{"id":"10.13039\/501100003399","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82072371"],"award-info":[{"award-number":["82072371"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82272390"],"award-info":[{"award-number":["82272390"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82402695"],"award-info":[{"award-number":["82402695"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82372313"],"award-info":[{"award-number":["82372313"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82102482"],"award-info":[{"award-number":["82102482"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular and Cellular Probes"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1016\/j.mcp.2026.102073","type":"journal-article","created":{"date-parts":[[2026,5,23]],"date-time":"2026-05-23T15:12:36Z","timestamp":1779549156000},"page":"102073","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["The role of RNA modifications in the pathological mechanisms and therapeutic targeting of multiple myeloma"],"prefix":"10.1016","volume":"88","author":[{"given":"Hao","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hefei","family":"Ren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chang","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liansheng","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuyue","family":"Zang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tingyu","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sijie","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weiwen","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lin","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"12","key":"10.1016\/j.mcp.2026.102073_bib1","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.6004\/jnccn.2023.0061","article-title":"Multiple myeloma, version 2.2024, NCCN clinical practice guidelines in oncology","volume":"21","author":"Kumar","year":"2023","journal-title":"J. Natl. Compr. Cancer Netw."},{"issue":"6","key":"10.1016\/j.mcp.2026.102073_bib2","first-page":"394","article-title":"Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"68","author":"Bray","year":"2018","journal-title":"CA Cancer J. Clin."},{"issue":"25","key":"10.1016\/j.mcp.2026.102073_bib3","doi-asserted-by":"crossref","first-page":"2582","DOI":"10.1056\/NEJMoa070389","article-title":"Clinical course and prognosis of smoldering (asymptomatic) multiple myeloma","volume":"356","author":"Kyle","year":"2007","journal-title":"N. Engl. J. Med."},{"issue":"2","key":"10.1016\/j.mcp.2026.102073_bib4","doi-asserted-by":"crossref","first-page":"116","DOI":"10.2174\/187152010790909344","article-title":"Multiple myeloma: a paradigm for translation of the cancer stem cell hypothesis","volume":"10","author":"Agarwal","year":"2010","journal-title":"Anti Cancer Agents Med. Chem."},{"issue":"9758","key":"10.1016\/j.mcp.2026.102073_bib5","doi-asserted-by":"crossref","first-page":"2075","DOI":"10.1016\/S0140-6736(10)61424-9","volume":"376","author":"Cavo","year":"2010","journal-title":"Lancet"},{"key":"10.1016\/j.mcp.2026.102073_bib6","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.bone.2018.03.011","article-title":"Bone marrow adiposity and multiple myeloma","volume":"118","author":"Morris","year":"2018","journal-title":"Bone"},{"issue":"1","key":"10.1016\/j.mcp.2026.102073_bib7","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/15476286.2024.2315385","article-title":"Single-cell analysis of the epitranscriptome: RNA modifications under the microscope","volume":"21","author":"Crespo-Garc\u00eda","year":"2024","journal-title":"RNA Biol."},{"key":"10.1016\/j.mcp.2026.102073_bib8","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.cbpa.2015.10.024","article-title":"RNA epigenetics--chemical messages for posttranscriptional gene regulation","volume":"30","author":"Roundtree","year":"2015","journal-title":"Curr. Opin. Chem. Biol."},{"key":"10.1016\/j.mcp.2026.102073_bib9","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.31311","article-title":"YTHDC1 mediates nuclear export of N6-methyladenosine methylated mRNAs","volume":"6","author":"Roundtree","year":"2017","journal-title":"eLife"},{"issue":"13","key":"10.1016\/j.mcp.2026.102073_bib10","doi-asserted-by":"crossref","first-page":"3369","DOI":"10.7150\/ijbs.61439","article-title":"The role of RNA m5C modification in cancer metastasis","volume":"17","author":"Zhang","year":"2021","journal-title":"Int. J. Biol. Sci."},{"key":"10.1016\/j.mcp.2026.102073_bib11","doi-asserted-by":"crossref","DOI":"10.3389\/fgene.2022.996950","article-title":"Comprehensive analysis of m7G modification patterns based on potential m7G regulators and tumor microenvironment infiltration characterization in lung adenocarcinoma","volume":"13","author":"Ma","year":"2022","journal-title":"Front. Genet."},{"issue":"11","key":"10.1016\/j.mcp.2026.102073_bib12","doi-asserted-by":"crossref","first-page":"1586","DOI":"10.1101\/gr.6493107","article-title":"Altered adenosine-to-inosine RNA editing in human cancer","volume":"17","author":"Paz","year":"2007","journal-title":"Genome Res."},{"issue":"4","key":"10.1016\/j.mcp.2026.102073_bib13","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1158\/2159-8290.CD-16-1292","article-title":"The epitranscriptome of noncoding RNAs in cancer","volume":"7","author":"Esteller","year":"2017","journal-title":"Cancer Discov."},{"issue":"6","key":"10.1016\/j.mcp.2026.102073_bib14","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1038\/s41568-020-0253-2","article-title":"Role of RNA modifications in cancer","volume":"20","author":"Barbieri","year":"2020","journal-title":"Nat. Rev. Cancer"},{"issue":"1","key":"10.1016\/j.mcp.2026.102073_bib15","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1186\/s12967-022-03750-8","article-title":"HNRNPA2B1-mediated m6A modification of TLR4 mRNA promotes progression of multiple myeloma","volume":"20","author":"Jia","year":"2022","journal-title":"J. Transl. Med."},{"issue":"12","key":"10.1016\/j.mcp.2026.102073_bib16","doi-asserted-by":"crossref","first-page":"2848","DOI":"10.1038\/s41375-025-02765-6","article-title":"Epitranscriptomic advances in normal and malignant hematopoiesis","volume":"39","author":"Eleftheriou","year":"2025","journal-title":"Leukemia"},{"key":"10.1016\/j.mcp.2026.102073_bib17","doi-asserted-by":"crossref","DOI":"10.3389\/fmolb.2023.1176416","article-title":"The essential roles of small non-coding RNAs and RNA modifications in normal and malignant hematopoiesis","volume":"10","author":"Cai","year":"2023","journal-title":"Front. Mol. Biosci."},{"key":"10.1016\/j.mcp.2026.102073_bib18","article-title":"A new perspective on hematological malignancies: m6A modification in immune microenvironment","volume":"15","author":"Yang","year":"2024","journal-title":"Front. Immunol."},{"key":"10.1016\/j.mcp.2026.102073_bib19","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1286820","article-title":"The regulation of antiviral innate immunity through non-m6A RNA modifications","volume":"14","author":"Shen","year":"2023","journal-title":"Front. Immunol."},{"issue":"9","key":"10.1016\/j.mcp.2026.102073_bib20","doi-asserted-by":"crossref","first-page":"1629","DOI":"10.1093\/carcin\/bgs212","article-title":"DNA methylation of microRNA genes in multiple myeloma","volume":"33","author":"Wong","year":"2012","journal-title":"Carcinogenesis"},{"issue":"12","key":"10.1016\/j.mcp.2026.102073_bib21","doi-asserted-by":"crossref","first-page":"1867","DOI":"10.1038\/s41591-018-0269-2","article-title":"Single cell dissection of plasma cell heterogeneity in symptomatic and asymptomatic myeloma","volume":"24","author":"Ledergor","year":"2018","journal-title":"Nat. Med."},{"issue":"5","key":"10.1016\/j.mcp.2026.102073_bib22","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1038\/s43018-020-0053-3","article-title":"Single-cell RNA sequencing reveals compromised immune microenvironment in precursor stages of multiple myeloma","volume":"1","author":"Zavidij","year":"2020","journal-title":"Nat. Cancer"},{"issue":"1","key":"10.1016\/j.mcp.2026.102073_bib23","doi-asserted-by":"crossref","DOI":"10.1002\/bip.23403","article-title":"Mechanisms of epitranscriptomic gene regulation","volume":"112","author":"Seo","year":"2020","journal-title":"Biopolymers"},{"issue":"1","key":"10.1016\/j.mcp.2026.102073_bib24","doi-asserted-by":"crossref","DOI":"10.3390\/genes10010049","article-title":"m6A mRNA destiny: chained to the rhYTHm by the YTH-Containing proteins","volume":"10","author":"Hazra","year":"2019","journal-title":"Genes"},{"issue":"1","key":"10.1016\/j.mcp.2026.102073_bib25","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.tips.2023.11.002","article-title":"The rise of epitranscriptomics: recent developments and future directions","volume":"45","author":"Cerneckis","year":"2023","journal-title":"Trends Pharmacol. Sci."},{"issue":"11","key":"10.1016\/j.mcp.2026.102073_bib26","doi-asserted-by":"crossref","DOI":"10.1002\/mco2.787","article-title":"RNA modification in normal hematopoiesis and hematologic malignancies","volume":"5","author":"Chen","year":"2024","journal-title":"MedComm"},{"key":"10.1016\/j.mcp.2026.102073_bib27","article-title":"Molecular characterization, clinical relevance and immune feature of m7G regulator genes across 33 cancer types","volume":"13","author":"Li","year":"2022","journal-title":"Front. Genet."},{"key":"10.1016\/j.mcp.2026.102073_bib28","doi-asserted-by":"crossref","first-page":"e20","DOI":"10.1017\/erm.2024.20","article-title":"Epitranscriptomics and cervical cancer: the emerging role of m6A, m5C and m1A RNA modifications","volume":"26","author":"Modi","year":"2024","journal-title":"Expert Rev. Mol. Med."},{"issue":"6","key":"10.1016\/j.mcp.2026.102073_bib29","doi-asserted-by":"crossref","first-page":"2235","DOI":"10.7150\/ijbs.64943","article-title":"ALKBH5 promotes multiple Myeloma tumorigenicity through inducing m6A-demethylation of SAV1 mRNA and myeloma stem cell phenotype","volume":"18","author":"Yu","year":"2022","journal-title":"Int. J. Biol. Sci."},{"issue":"3","key":"10.1016\/j.mcp.2026.102073_bib30","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1016\/j.ymthe.2021.12.012","article-title":"FTO promotes multiple myeloma progression by posttranscriptional activation of HSF1 in an m6A-YTHDF2-dependent manner","volume":"30","author":"Xu","year":"2021","journal-title":"Mol. Ther."},{"issue":"8","key":"10.1016\/j.mcp.2026.102073_bib31","doi-asserted-by":"crossref","DOI":"10.1080\/15384101.2023.2170521","article-title":"Metformin attenuates multiple myeloma cell proliferation and encourages apoptosis by suppressing METTL3-mediated m6A methylation of THRAP3, RBM25, and USP4","volume":"22","author":"Chen","year":"2023","journal-title":"Cell Cycle"},{"issue":"4","key":"10.1016\/j.mcp.2026.102073_bib32","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1038\/s41417-022-00429-6","article-title":"FTO promotes bortezomib resistance via m6A-dependent destabilization of SOD2 expression in multiple myeloma","volume":"30","author":"Wang","year":"2022","journal-title":"Cancer Gene Ther."},{"issue":"3","key":"10.1016\/j.mcp.2026.102073_bib33","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1038\/s41388-021-02095-8","article-title":"RNA demethylase ALKBH5 promotes tumorigenesis in multiple myeloma via TRAF1-mediated activation of NF-\u03baB and MAPK signaling pathways","volume":"41","author":"Qu","year":"2021","journal-title":"Oncogene"},{"key":"10.1016\/j.mcp.2026.102073_bib34","doi-asserted-by":"crossref","first-page":"3326","DOI":"10.1182\/blood-2021-149622","article-title":"ALKBH5 functions as an oncogene in multiple myeloma","volume":"138","author":"Qu","year":"2021","journal-title":"Blood"},{"key":"10.1016\/j.mcp.2026.102073_bib35","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2025.116998","article-title":"ALKBH5 reverses romidepsin-mediated anti-multiple myeloma activity via regulation of m6A modification of FOXM1","volume":"239","author":"Zhang","year":"2025","journal-title":"Biochem. Pharmacol."},{"issue":"5","key":"10.1016\/j.mcp.2026.102073_bib36","doi-asserted-by":"crossref","first-page":"2033","DOI":"10.1007\/s10565-021-09690-1","article-title":"METTL3 facilitates multiple myeloma tumorigenesis by enhancing YY1 stability and pri-microRNA-27 maturation in m6A-dependent manner","volume":"39","author":"Che","year":"2022","journal-title":"Cell Biol. Toxicol."},{"issue":"7","key":"10.1016\/j.mcp.2026.102073_bib37","doi-asserted-by":"crossref","first-page":"1801","DOI":"10.1007\/s00277-023-05283-6","article-title":"m6A methyltransferase METTL3 facilitates multiple myeloma cell growth through the m6A modification of BZW2","volume":"102","author":"Huang","year":"2023","journal-title":"Ann. Hematol."},{"issue":"8","key":"10.1016\/j.mcp.2026.102073_bib38","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1038\/s41419-023-06036-z","article-title":"PRMT1 methylation of WTAP promotes multiple myeloma tumorigenesis by activating oxidative phosphorylation via m6A modification of NDUFS6","volume":"14","author":"Jia","year":"2023","journal-title":"Cell Death Dis."},{"issue":"1","key":"10.1016\/j.mcp.2026.102073_bib39","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1007\/s10565-024-09904-2","article-title":"KIAA1429 increases FOXM1 expression through YTHDF1-mediated m6A modification to promote aerobic glycolysis and tumorigenesis in multiple myeloma","volume":"40","author":"Wu","year":"2024","journal-title":"Cell Biol. Toxicol."},{"key":"10.1016\/j.mcp.2026.102073_bib40","series-title":"21st IMS Annual Meeting","author":"Sun","year":"2024"},{"issue":"2","key":"10.1016\/j.mcp.2026.102073_bib41","first-page":"588","article-title":"Pan-cancer analysis of Methyltransferase-like 16 (METTL16) and validated in colorectal cancer","volume":"17","author":"Liu","year":"2025","journal-title":"Aging (Albany NY)"},{"issue":"14","key":"10.1016\/j.mcp.2026.102073_bib42","doi-asserted-by":"crossref","first-page":"6602","DOI":"10.1111\/jcmm.16664","article-title":"METTL16 promotes cell proliferation by up-regulating cyclin D1 expression in gastric cancer","volume":"25","author":"Wang","year":"2021","journal-title":"J. Cell Mol. Med."},{"issue":"9","key":"10.1016\/j.mcp.2026.102073_bib43","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0292212","article-title":"NOP2\/Sun RNA methyltransferase 2 is a potential pan-cancer prognostic biomarker and is related to immunity","volume":"18","author":"Zheng","year":"2023","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.mcp.2026.102073_bib44","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1186\/s43556-023-00139-x","article-title":"RNA modification: mechanisms and therapeutic targets","volume":"4","author":"Qiu","year":"2023","journal-title":"Mol Biomed"},{"issue":"19","key":"10.1016\/j.mcp.2026.102073_bib45","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2024.e38660","article-title":"The role of m5C RNA modification in cancer development and therapy","volume":"10","author":"Yu","year":"2024","journal-title":"Heliyon"},{"issue":"8","key":"10.1016\/j.mcp.2026.102073_bib46","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1038\/s41556-019-0361-y","article-title":"5-methylcytosine promotes pathogenesis of bladder cancer through stabilizing mRNAs","volume":"21","author":"Chen","year":"2019","journal-title":"Nat. Cell Biol."},{"issue":"52","key":"10.1016\/j.mcp.2026.102073_bib47","doi-asserted-by":"crossref","first-page":"18134","DOI":"10.1074\/jbc.RA119.012009","article-title":"NSun2 promotes cell migration through methylating autotaxin mRNA","volume":"295","author":"Xu","year":"2020","journal-title":"J. Biol. Chem."},{"issue":"1","key":"10.1016\/j.mcp.2026.102073_bib48","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1186\/s40164-024-00477-8","article-title":"METTL1 mediated tRNA m7G modification promotes leukaemogenesis of AML via tRNA regulated translational control","volume":"13","author":"Zhao","year":"2024","journal-title":"Exp. Hematol. Oncol."},{"issue":"16","key":"10.1016\/j.mcp.2026.102073_bib49","doi-asserted-by":"crossref","DOI":"10.1016\/j.molcel.2021.07.003","article-title":"N7-Methylguanosine tRNA modification enhances oncogenic mRNA translation and promotes intrahepatic cholangiocarcinoma progression","volume":"81","author":"Dai","year":"2021","journal-title":"Mol Cell."},{"issue":"16","key":"10.1016\/j.mcp.2026.102073_bib50","doi-asserted-by":"crossref","DOI":"10.1016\/j.molcel.2021.06.031","article-title":"METTL1-mediated m7G modification of Arg-TCT tRNA drives oncogenic transformation","volume":"81","author":"Orellana","year":"2021","journal-title":"Mol Cell"},{"issue":"1","key":"10.1016\/j.mcp.2026.102073_bib51","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1038\/s41421-023-00562-y","article-title":"Structural insight into how WDR4 promotes the tRNA N7-methylguanosine methyltransferase activity of METTL1","volume":"9","author":"Jin","year":"2023","journal-title":"Cell Discov."},{"issue":"7943","key":"10.1016\/j.mcp.2026.102073_bib52","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1038\/s41586-022-05565-5","article-title":"Structures and mechanisms of tRNA methylation by METTL1-WDR4","volume":"613","author":"Ruiz-Arroyo","year":"2023","journal-title":"Nature"},{"issue":"10","key":"10.1016\/j.mcp.2026.102073_bib53","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1016\/j.cub.2006.04.027","article-title":"The RNA methyltransferase misu (NSun2) mediates Myc-induced proliferation and is upregulated in tumors","volume":"16","author":"Frye","year":"2006","journal-title":"Curr. Biol."},{"issue":"3","key":"10.1016\/j.mcp.2026.102073_bib54","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1634\/theoncologist.2009-0003","article-title":"Myeloma bone disease: recent advances in biology, diagnosis, and treatment","volume":"14","author":"Sezer","year":"2009","journal-title":"Oncologist"},{"issue":"6","key":"10.1016\/j.mcp.2026.102073_bib55","doi-asserted-by":"crossref","DOI":"10.3390\/ijms23063112","article-title":"Pathogenesis and treatment of myeloma-related bone disease","volume":"23","author":"Gau","year":"2022","journal-title":"Int. J. Mol. Sci."},{"issue":"12","key":"10.1016\/j.mcp.2026.102073_bib56","doi-asserted-by":"crossref","DOI":"10.3390\/ijms22126208","article-title":"Myeloma bone disease: a comprehensive review","volume":"22","author":"Mukkamalla","year":"2021","journal-title":"Int. J. Mol. Sci."},{"issue":"3","key":"10.1016\/j.mcp.2026.102073_bib57","article-title":"Non-coding RNAs in multiple myeloma bone disease pathophysiology","volume":"6","author":"Raimondi","year":"2020","journal-title":"Noncoding RNA"},{"issue":"18","key":"10.1016\/j.mcp.2026.102073_bib58","doi-asserted-by":"crossref","first-page":"7760","DOI":"10.7150\/thno.76852","article-title":"m6A reader hnRNPA2B1 drives multiple myeloma osteolytic bone disease","volume":"12","author":"Liu","year":"2022","journal-title":"Theranostics"},{"key":"10.1016\/j.mcp.2026.102073_bib59","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2020.608815","article-title":"Exosomes in the pathogenesis and treatment of multiple myeloma in the context of the bone marrow microenvironment","volume":"10","author":"Chen","year":"2020","journal-title":"Front. Oncol."},{"key":"10.1016\/j.mcp.2026.102073_bib60","doi-asserted-by":"crossref","first-page":"2980","DOI":"10.1038\/ncomms3980","article-title":"Sumoylated hnRNPA2B1 controls the sorting of miRNAs into exosomes through binding to specific motifs","volume":"4","author":"Villarroya-Beltri","year":"2013","journal-title":"Nat. Commun."},{"issue":"13","key":"10.1016\/j.mcp.2026.102073_bib61","doi-asserted-by":"crossref","DOI":"10.3390\/ijms20133236","article-title":"Extracellular vesicles enhance multiple myeloma metastatic dissemination","volume":"20","author":"Colombo","year":"2019","journal-title":"Int. J. Mol. Sci."},{"issue":"11","key":"10.1016\/j.mcp.2026.102073_bib62","doi-asserted-by":"crossref","DOI":"10.3390\/cells10113185","article-title":"Role of extracellular vesicle-based cell-to-cell communication in multiple myeloma progression","volume":"10","author":"Saltarella","year":"2021","journal-title":"Cells"},{"issue":"17","key":"10.1016\/j.mcp.2026.102073_bib63","doi-asserted-by":"crossref","DOI":"10.3390\/ijms231710118","article-title":"Extracellular vesicles in haematological disorders: a friend or a foe?","volume":"23","author":"Lazana","year":"2022","journal-title":"Int. J. Mol. Sci."},{"issue":"6","key":"10.1016\/j.mcp.2026.102073_bib64","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1002\/jbmr.3689","article-title":"Cooperation of PU.1 with IRF8 and NFATc1 defines chromatin landscapes during RANKL-induced osteoclastogenesis","volume":"34","author":"Izawa","year":"2019","journal-title":"J. Bone Miner. Res."},{"issue":"22","key":"10.1016\/j.mcp.2026.102073_bib65","doi-asserted-by":"crossref","DOI":"10.3390\/cancers14225575","article-title":"Extracellular vesicles in multiple myeloma-cracking the code to a better understanding of the disease","volume":"14","author":"Iskrzak","year":"2022","journal-title":"Cancers (Basel)"},{"issue":"1","key":"10.1016\/j.mcp.2026.102073_bib66","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1002\/cam4.1181","article-title":"The mechanism study of miR-125b in occurrence and progression of multiple myeloma","volume":"7","author":"Gao","year":"2017","journal-title":"Cancer Med."},{"key":"10.1016\/j.mcp.2026.102073_bib67","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2021.689538","article-title":"The emerging role of extracellular vesicle-associated RNAs in the multiple myeloma microenvironment","volume":"11","author":"Khalife","year":"2021","journal-title":"Front. Oncol."},{"issue":"5","key":"10.1016\/j.mcp.2026.102073_bib68","doi-asserted-by":"crossref","first-page":"421","DOI":"10.4252\/wjsc.v15.i5.421","article-title":"Communication between bone marrow mesenchymal stem cells and multiple myeloma cells: impact on disease progression","volume":"15","author":"Garc\u00eda-S\u00e1nchez","year":"2023","journal-title":"World J. Stem Cell."},{"key":"10.1016\/j.mcp.2026.102073_bib69","doi-asserted-by":"crossref","first-page":"849","DOI":"10.2147\/OTT.S425523","article-title":"HOXC cluster antisense RNA 3, a novel long non-coding RNA as an oncological biomarker and therapeutic target in human malignancies","volume":"16","author":"Xie","year":"2023","journal-title":"OncoTargets Ther."},{"issue":"35","key":"10.1016\/j.mcp.2026.102073_bib70","doi-asserted-by":"crossref","first-page":"12885","DOI":"10.1073\/pnas.0806202105","article-title":"MicroRNAs regulate critical genes associated with multiple myeloma pathogenesis","volume":"105","author":"Pichiorri","year":"2008","journal-title":"Proc. Natl. Acad. Sci. U. S. A"},{"issue":"1","key":"10.1016\/j.mcp.2026.102073_bib71","doi-asserted-by":"crossref","DOI":"10.1038\/nm.3026","article-title":"miR-214 targets ATF4 to inhibit bone formation","volume":"19","author":"Wang","year":"2012","journal-title":"Nat. Med."},{"issue":"1","key":"10.1016\/j.mcp.2026.102073_bib72","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1186\/s13045-021-01066-6","article-title":"HNRNPA2B1 promotes multiple myeloma progression by increasing AKT3 expression via m6A-dependent stabilization of ILF3 mRNA","volume":"14","author":"Jiang","year":"2021","journal-title":"J. Hematol. Oncol."},{"issue":"7","key":"10.1016\/j.mcp.2026.102073_bib73","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1038\/s41419-021-03915-1","article-title":"Circ_0008542 in osteoblast exosomes promotes osteoclast-induced bone resorption through m6A methylation","volume":"12","author":"Wang","year":"2021","journal-title":"Cell Death Dis."},{"issue":"2","key":"10.1016\/j.mcp.2026.102073_bib74","doi-asserted-by":"crossref","DOI":"10.3390\/ijms24021403","article-title":"METTL3 regulates osteoclast biological behaviors via iNOS\/NO-Mediated mitochondrial dysfunction in inflammatory conditions","volume":"24","author":"Li","year":"2023","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"10.1016\/j.mcp.2026.102073_bib75","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1038\/s42003-024-06918-8","article-title":"Aberrant NSUN2-mediated m5C modification of exosomal LncRNA MALAT1 induced RANKL-mediated bone destruction in multiple myeloma","volume":"7","author":"Yu","year":"2024","journal-title":"Commun. Biol."},{"key":"10.1016\/j.mcp.2026.102073_bib76","article-title":"5-methylcytosine methylation of MALAT1 promotes resistance to sorafenib in hepatocellular carcinoma through ELAVL1\/SLC7A11-mediated ferroptosis","volume":"78","author":"Shi","year":"2024","journal-title":"Drug Resist. Updates"},{"key":"10.1016\/j.mcp.2026.102073_bib77","doi-asserted-by":"crossref","first-page":"781","DOI":"10.2147\/IJN.S395607","article-title":"Osteoblasts-Derived exosomal lncRNA-MALAT1 promotes osteoclastogenesis by targeting the miR-124\/NFATc1 signaling axis in bone marrow-derived macrophages","volume":"18","author":"Zhang","year":"2023","journal-title":"Int. J. Nanomed."},{"issue":"36","key":"10.1016\/j.mcp.2026.102073_bib78","doi-asserted-by":"crossref","first-page":"17980","DOI":"10.1073\/pnas.1905489116","article-title":"The RNA demethylase FTO is required for maintenance of bone mass and functions to protect osteoblasts from genotoxic damage","volume":"116","author":"Zhang","year":"2019","journal-title":"Proc. Natl. Acad. Sci. U. S. A"},{"issue":"13","key":"10.1016\/j.mcp.2026.102073_bib79","doi-asserted-by":"crossref","first-page":"3431","DOI":"10.1158\/0008-5472.CAN-20-4107","article-title":"The emerging roles of RNA m6A methylation and demethylation as critical regulators of tumorigenesis, drug sensitivity, and resistance","volume":"81","author":"Lan","year":"2021","journal-title":"Cancer Res."},{"issue":"1","key":"10.1016\/j.mcp.2026.102073_bib80","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1186\/s13046-021-02088-1","article-title":"ALKBH5-HOXA10 loop-mediated JAK2 m6A demethylation and cisplatin resistance in epithelial ovarian cancer","volume":"40","author":"Nie","year":"2021","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"10.1016\/j.mcp.2026.102073_bib81","article-title":"M6A demethylase ALKBH5 regulates FOXO1 mRNA stability and chemoresistance in triple-negative breast cancer","volume":"69","author":"Liu","year":"2023","journal-title":"Redox Biol."},{"issue":"2","key":"10.1016\/j.mcp.2026.102073_bib82","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1038\/s41419-018-1219-0","article-title":"LncRNA H19 overexpression induces bortezomib resistance in multiple myeloma by targeting MCL-1 via miR-29b-3p","volume":"10","author":"Pan","year":"2019","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.mcp.2026.102073_bib83","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2024.1383232","article-title":"N6-methyladenosine-modified circ_0000337 sustains bortezomib resistance in multiple myeloma by regulating DNA repair","volume":"12","author":"Jiang","year":"2024","journal-title":"Front. Cell Dev. Biol."},{"issue":"20","key":"10.1016\/j.mcp.2026.102073_bib84","doi-asserted-by":"crossref","first-page":"4384","DOI":"10.1158\/0008-5472.CAN-15-0457","article-title":"Targeting the miR-221-222\/PUMA\/BAK\/BAX pathway abrogates dexamethasone resistance in multiple myeloma","volume":"75","author":"Zhao","year":"2015","journal-title":"Cancer Res."},{"issue":"1","key":"10.1016\/j.mcp.2026.102073_bib85","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1186\/s13045-017-0538-4","article-title":"Role of tumor suppressor p53 and micro-RNA interplay in multiple myeloma pathogenesis","volume":"10","author":"Abdi","year":"2017","journal-title":"J. Hematol. Oncol."},{"issue":"1","key":"10.1016\/j.mcp.2026.102073_bib86","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1007\/s10238-025-01624-z","article-title":"N6-methyladenosine-mediated upregulation of H19 promotes resistance to bortezomib by modulating the miR-184\/CARM1 axis in multiple myeloma","volume":"25","author":"Wang","year":"2025","journal-title":"Clin. Exp. Med."},{"key":"10.1016\/j.mcp.2026.102073_bib87","doi-asserted-by":"crossref","DOI":"10.1093\/gpbjnl\/qzaf076","article-title":"METTL1\/WDR4-mediated m7G hypermethylation of SCLT1 mRNA promotes gefitinib resistance in NSCLC","author":"Zhou","year":"2025","journal-title":"Genom. Proteom. Bioinform."},{"key":"10.1016\/j.mcp.2026.102073_bib88","doi-asserted-by":"crossref","DOI":"10.3389\/fgene.2022.920164","article-title":"m5C Regulator-mediated methylation modification clusters contribute to the immune microenvironment regulation of multiple myeloma","volume":"13","author":"Ren","year":"2022","journal-title":"Front. Genet."},{"issue":"1","key":"10.1016\/j.mcp.2026.102073_bib89","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1182\/blood.V100.1.230","article-title":"Dendritic cells are functionally defective in multiple myeloma: the role of interleukin-6","volume":"100","author":"Ratta","year":"2002","journal-title":"Blood"},{"issue":"2","key":"10.1016\/j.mcp.2026.102073_bib90","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1038\/sj.mt.6300369","article-title":"Overcoming immune tolerance against multiple myeloma with lentiviral calnexin-engineered dendritic cells","volume":"16","author":"Han","year":"2007","journal-title":"Mol. Ther."},{"issue":"7743","key":"10.1016\/j.mcp.2026.102073_bib91","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1038\/s41586-019-0916-x","article-title":"Anti-tumour immunity controlled through mRNA m6A methylation and YTHDF1 in dendritic cells","volume":"566","author":"Han","year":"2019","journal-title":"Nature"},{"issue":"4","key":"10.1016\/j.mcp.2026.102073_bib92","article-title":"Novel insight into RNA modifications in tumor immunity: promising targets to prevent tumor immune escape","volume":"4","author":"Kong","year":"2023","journal-title":"Innovation"},{"issue":"3","key":"10.1016\/j.mcp.2026.102073_bib93","article-title":"RNA N6-Methyladenosine-Binding protein YTHDFs redundantly attenuate cancer immunity by downregulating IFN-\u03b3 signaling in gastric cancer","volume":"12","author":"Jang","year":"2024","journal-title":"Adv. Sci. (Weinh.)"},{"issue":"3","key":"10.1016\/j.mcp.2026.102073_bib94","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1182\/blood-2016-08-731885","article-title":"Targeting the PD-1\/PD-L1 axis in multiple myeloma: a dream or a reality?","volume":"129","author":"Rosenblatt","year":"2016","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.mcp.2026.102073_bib95","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1186\/s13045-019-0819-1","article-title":"CAR-T \"the living drugs\", immune checkpoint inhibitors, and precision medicine: a new era of cancer therapy","volume":"12","author":"Liu","year":"2019","journal-title":"J. Hematol. Oncol."},{"issue":"2","key":"10.1016\/j.mcp.2026.102073_bib96","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1038\/s41375-019-0558-x","article-title":"Targeting tryptophan catabolic kynurenine pathway enhances antitumor immunity and cytotoxicity in multiple myeloma","volume":"34","author":"Ray","year":"2019","journal-title":"Leukemia"},{"issue":"7","key":"10.1016\/j.mcp.2026.102073_bib97","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1158\/2326-6066.CIR-24-1179","article-title":"METTL3 inhibition restores PD-L1 expression and CD8+ T-cell cytotoxic function in immunotherapy-treated gastric cancer","volume":"13","author":"Fang","year":"2025","journal-title":"Cancer Immunol. Res."},{"issue":"4","key":"10.1016\/j.mcp.2026.102073_bib98","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1002\/hep.32585","article-title":"Eliminating METTL1-mediated accumulation of PMN-MDSCs prevents hepatocellular carcinoma recurrence after radiofrequency ablation","volume":"77","author":"Zeng","year":"2022","journal-title":"Hepatology"},{"issue":"2","key":"10.1016\/j.mcp.2026.102073_bib99","first-page":"538","article-title":"N7-methylguanosine regulatory genes well represented by METTL1 define vastly different prognostic, immune and therapy landscapes in adrenocortical carcinoma","volume":"13","author":"Xu","year":"2023","journal-title":"Am. J. Cancer Res."},{"issue":"1","key":"10.1016\/j.mcp.2026.102073_bib100","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-022-25698-x","article-title":"N7-methylguanosine methylation-related regulator genes as biological markers in predicting prognosis for melanoma","volume":"12","author":"Deng","year":"2022","journal-title":"Sci. Rep."},{"key":"10.1016\/j.mcp.2026.102073_bib101","doi-asserted-by":"crossref","DOI":"10.1155\/2022\/2735251","article-title":"Identification of six N7-Methylguanosine-Related miRNA signatures to predict the overall survival and immune landscape of triple-negative breast cancer through in Silico analysis","volume":"2022","author":"Xu","year":"2022","journal-title":"J. Oncol."},{"key":"10.1016\/j.mcp.2026.102073_bib102","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbo.2025.100695","article-title":"Regulatory role of the METTL3\/MALAT1 axis in multiple myeloma progression","volume":"53","author":"Lu","year":"2025","journal-title":"J. Bone Oncol."},{"issue":"17","key":"10.1016\/j.mcp.2026.102073_bib103","doi-asserted-by":"crossref","first-page":"18114","DOI":"10.1021\/acs.jmedchem.5c01570","article-title":"Small-Molecule inhibitors targeting RNA m6A modifiers for cancer therapeutics: latest advances and future perspectives","volume":"68","author":"Tang","year":"2025","journal-title":"J. Med. Chem."},{"issue":"1","key":"10.1016\/j.mcp.2026.102073_bib104","article-title":"IGF2BP1 promotes multiple myeloma with chromosome 1q gain via increasing CDC5L expression in an m6A-dependent manner","volume":"12","author":"Xu","year":"2024","journal-title":"Genes Dis."},{"issue":"9","key":"10.1016\/j.mcp.2026.102073_bib105","doi-asserted-by":"crossref","first-page":"1948","DOI":"10.1038\/s41375-018-0067-3","article-title":"Drugging the lncRNA MALAT1 via LNA gapmeR ASO inhibits gene expression of proteasome subunits and triggers anti-multiple myeloma activity","volume":"32","author":"Amodio","year":"2018","journal-title":"Leukemia"},{"issue":"12","key":"10.1016\/j.mcp.2026.102073_bib106","doi-asserted-by":"crossref","DOI":"10.1002\/ctm2.661","article-title":"METTL1 promotes hepatocarcinogenesis via m7 G tRNA modification-dependent translation control","volume":"11","author":"Chen","year":"2021","journal-title":"Clin. Transl. Med."},{"issue":"1","key":"10.1016\/j.mcp.2026.102073_bib107","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1186\/s13045-023-01477-7","article-title":"Methyltransferase-like proteins in cancer biology and potential therapeutic targeting","volume":"16","author":"Qi","year":"2023","journal-title":"J. Hematol. Oncol."},{"issue":"1","key":"10.1016\/j.mcp.2026.102073_bib108","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-023-41974-w","article-title":"Distinct N7-methylguanosine profiles of circular RNAs in drug-resistant acute myeloid leukemia","volume":"13","author":"Fu","year":"2023","journal-title":"Sci. Rep."},{"issue":"13","key":"10.1016\/j.mcp.2026.102073_bib109","doi-asserted-by":"crossref","first-page":"4667","DOI":"10.7150\/thno.87316","article-title":"Targeting materials and strategies for RNA delivery","volume":"13","author":"Lin","year":"2023","journal-title":"Theranostics"},{"issue":"4","key":"10.1016\/j.mcp.2026.102073_bib110","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1007\/s12195-023-00774-y","article-title":"siRNA lipid-polymer nanoparticles targeting E-Selectin and Cyclophilin A in bone marrow for combination multiple myeloma therapy","volume":"16","author":"Figueroa-Espada","year":"2023","journal-title":"Cell. Mol. Bioeng."},{"issue":"6","key":"10.1016\/j.mcp.2026.102073_bib111","doi-asserted-by":"crossref","first-page":"1364","DOI":"10.1158\/1535-7163.MCT-15-0985","article-title":"Therapeutic targeting of miR-29b\/HDAC4 epigenetic loop in multiple myeloma","volume":"15","author":"Amodio","year":"2016","journal-title":"Mol. Cancer Therapeut."},{"issue":"3","key":"10.1016\/j.mcp.2026.102073_bib112","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1016\/j.ymthe.2019.01.012","article-title":"miR-221\/222-Mediated inhibition of autophagy promotes dexamethasone resistance in multiple myeloma","volume":"27","author":"Xu","year":"2019","journal-title":"Mol. Ther."},{"issue":"1","key":"10.1016\/j.mcp.2026.102073_bib113","doi-asserted-by":"crossref","first-page":"4036","DOI":"10.1038\/s41467-022-31636-2","article-title":"An LNA-amide modification that enhances the cell uptake and activity of phosphorothioate exon-skipping oligonucleotides","volume":"13","author":"Baker","year":"2022","journal-title":"Nat. Commun."},{"issue":"3","key":"10.1016\/j.mcp.2026.102073_bib114","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1038\/nbt.3765","article-title":"The chemical evolution of oligonucleotide therapies of clinical utility","volume":"35","author":"Khvorova","year":"2017","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.mcp.2026.102073_bib115","article-title":"Comprehensive analysis of m6A RNA methylation regulators in the prognosis and immune microenvironment of multiple myeloma","volume":"11","author":"Liu","year":"2021","journal-title":"Front. Oncol."},{"key":"10.1016\/j.mcp.2026.102073_bib116","article-title":"Comprehensive analysis of a novel RNA modifications-related model in the prognostic characterization, immune landscape and drug therapy of bladder cancer","volume":"14","author":"Zhang","year":"2023","journal-title":"Front. Genet."},{"key":"10.1016\/j.mcp.2026.102073_bib117","doi-asserted-by":"crossref","first-page":"875","DOI":"10.3389\/fonc.2020.00875","article-title":"Gene signatures and prognostic values of m6A genes in nasopharyngeal carcinoma","volume":"10","author":"Lu","year":"2020","journal-title":"Front. Oncol."},{"issue":"2","key":"10.1016\/j.mcp.2026.102073_bib118","doi-asserted-by":"crossref","DOI":"10.1016\/j.isci.2024.108897","article-title":"The implication of integrative multiple RNA modification-based subtypes in gastric cancer immunotherapy and prognosis","volume":"27","author":"Zhang","year":"2024","journal-title":"iScience"},{"issue":"2","key":"10.1016\/j.mcp.2026.102073_bib119","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1002\/iub.2678","article-title":"N6-methyladenosine regulators are potential prognostic biomarkers for multiple myeloma","volume":"75","author":"Wang","year":"2022","journal-title":"IUBMB Life"},{"issue":"7","key":"10.1016\/j.mcp.2026.102073_bib120","doi-asserted-by":"crossref","first-page":"3164","DOI":"10.7150\/thno.41687","article-title":"Dysregulations of functional RNA modifications in cancer, cancer stemness and cancer therapeutics","volume":"10","author":"Uddin","year":"2020","journal-title":"Theranostics"},{"issue":"2","key":"10.1016\/j.mcp.2026.102073_bib121","doi-asserted-by":"crossref","DOI":"10.1038\/s41571-019-0267-4","article-title":"Combining epigenetic drugs with other therapies for solid tumours - past lessons and future promise","volume":"17","author":"Morel","year":"2019","journal-title":"Nat. Rev. Clin. Oncol."},{"issue":"8","key":"10.1016\/j.mcp.2026.102073_bib122","doi-asserted-by":"crossref","first-page":"517","DOI":"10.2217\/epi-2023-0142","article-title":"Role of epigenetic drugs in sensitizing cancers to anticancer therapies: emerging trends and clinical advancements","volume":"15","author":"Singh","year":"2023","journal-title":"Epigenomics"},{"key":"10.1016\/j.mcp.2026.102073_bib123","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2024.1463847","article-title":"RNA modifications in cancer immune therapy: regulators of immune cells and immune checkpoints","volume":"15","author":"Qin","year":"2024","journal-title":"Front. Immunol."},{"key":"10.1016\/j.mcp.2026.102073_bib124","article-title":"Developing an m5C regulator-mediated RNA methylation modification signature to predict prognosis and immunotherapy efficacy in rectal cancer","volume":"14","author":"Zhang","year":"2023","journal-title":"Front. Immunol."},{"issue":"32","key":"10.1016\/j.mcp.2026.102073_bib125","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.abd2605","article-title":"Repurposing RNA sequencing for discovery of RNA modifications in clinical cohorts","volume":"7","author":"Tan","year":"2021","journal-title":"Sci. Adv."},{"issue":"4","key":"10.1016\/j.mcp.2026.102073_bib126","doi-asserted-by":"crossref","DOI":"10.3390\/cancers15041232","article-title":"Understanding the epitranscriptome for avant-garde brain tumour diagnostics","volume":"15","author":"T\u0171zesi","year":"2023","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.mcp.2026.102073_bib127","doi-asserted-by":"crossref","first-page":"3015","DOI":"10.1016\/j.csbj.2021.05.030","article-title":"Recent advances in functional annotation and prediction of the epitranscriptome","volume":"19","author":"Zhang","year":"2021","journal-title":"Comput. Struct. Biotechnol. J."},{"key":"10.1016\/j.mcp.2026.102073_bib128","doi-asserted-by":"crossref","DOI":"10.1016\/j.optlastec.2023.110357","article-title":"WaveFlex Biosensor: MXene-Immobilized W-shaped Fiber-Based LSPR sensor for highly selective tyramine detection","volume":"171","author":"Singh","year":"2024","journal-title":"Opt Laser. Technol."},{"issue":"15","key":"10.1016\/j.mcp.2026.102073_bib129","doi-asserted-by":"crossref","first-page":"25789","DOI":"10.1364\/OE.530348","article-title":"Hump-shaped seven-core fiber-based WaveFlex biosensor for rapid detection of glyphosate pesticides in real food samples","volume":"32","author":"Zhang","year":"2024","journal-title":"Opt. Express"},{"issue":"15","key":"10.1016\/j.mcp.2026.102073_bib130","doi-asserted-by":"crossref","first-page":"25772","DOI":"10.1364\/OE.530225","article-title":"Four-core fiber-based multi-tapered WaveFlex biosensor for rapid detection of Vibrio parahaemolyticus using nanoparticles-enhanced probes","volume":"32","author":"Fu","year":"2024","journal-title":"Opt. Express"},{"key":"10.1016\/j.mcp.2026.102073_bib131","article-title":"Laser-Induced graphene-based Fabry-P\u00e9rot cavity label-free immunosensors for the quantification of cortisol","volume":"7","author":"Gomes","year":"2024","journal-title":"Sens. Acutators Rep."},{"issue":"7","key":"10.1016\/j.mcp.2026.102073_bib132","doi-asserted-by":"crossref","first-page":"6661","DOI":"10.1109\/JSEN.2022.3154385","article-title":"MXenes-Based fiber-optic SPR sensor for colorectal cancer diagnosis","volume":"22","author":"Kaur","year":"2022","journal-title":"IEEE Sens. J."},{"issue":"6","key":"10.1016\/j.mcp.2026.102073_bib133","doi-asserted-by":"crossref","first-page":"391","DOI":"10.37349\/etat.2020.00024","article-title":"Use of liquid biopsy in monitoring therapeutic resistance in EGFR oncogene addicted NSCLC","volume":"1","author":"Iacovino","year":"2020","journal-title":"Explor Target Antitumor Ther."},{"issue":"3","key":"10.1016\/j.mcp.2026.102073_bib134","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.molmed.2018.12.009","article-title":"Principles of resistance to targeted cancer therapy: lessons from basic and translational cancer biology","volume":"25","author":"Sabnis","year":"2019","journal-title":"Trends Mol. Med."},{"issue":"10","key":"10.1016\/j.mcp.2026.102073_bib135","doi-asserted-by":"crossref","DOI":"10.3390\/cancers12102996","article-title":"Epigenetic aberrations in multiple myeloma","volume":"12","author":"Caprio","year":"2020","journal-title":"Cancers (Basel)"},{"issue":"5","key":"10.1016\/j.mcp.2026.102073_bib136","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1038\/s41422-018-0034-6","article-title":"RNA N6-methyladenosine modification in cancers: current status and perspectives","volume":"28","author":"Deng","year":"2018","journal-title":"Cell Res."},{"issue":"10","key":"10.1016\/j.mcp.2026.102073_bib137","doi-asserted-by":"crossref","first-page":"2250","DOI":"10.1038\/s41375-018-0104-2","article-title":"Targeting the MALAT1\/PARP1\/LIG3 complex induces DNA damage and apoptosis in multiple myeloma","volume":"32","author":"Hu","year":"2018","journal-title":"Leukemia"},{"issue":"3","key":"10.1016\/j.mcp.2026.102073_bib138","article-title":"RNA m6A modification in cancers: molecular mechanisms and potential clinical applications","volume":"1","author":"Gu","year":"2020","journal-title":"Innovation"}],"container-title":["Molecular and Cellular Probes"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0890850826000137?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0890850826000137?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,5]],"date-time":"2026-07-05T07:59:23Z","timestamp":1783238363000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0890850826000137"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":138,"alternative-id":["S0890850826000137"],"URL":"https:\/\/doi.org\/10.1016\/j.mcp.2026.102073","relation":{},"ISSN":["0890-8508"],"issn-type":[{"value":"0890-8508","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The role of RNA modifications in the pathological mechanisms and therapeutic targeting of multiple myeloma","name":"articletitle","label":"Article Title"},{"value":"Molecular and Cellular Probes","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.mcp.2026.102073","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"102073"}}